Clari Vest Asset Management LLC Immuno Gen, Inc. Transaction History

Clari Vest Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.46 - $29.95 $426,505 - $1.03 Million	-34,230 Reduced 62.93%	20,161 $597,000
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $333,383 - $470,144	23,661 Added 77.0%	54,391 $863,000
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $323,133 - $1.73 Million	-86,169 Reduced 73.71%	30,730 $579,000
Q1 2023 May 08, 2023	SELL	$3.67 - $4.92 $370 - $496	-101 Reduced 0.09%	116,899 $449,000
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $8,190 - $11,358	-1,800 Reduced 1.52%	117,000 $580,000
Q3 2022 Nov 10, 2022	BUY	$4.48 - $6.47 $532,224 - $768,636	118,800 New	118,800 $568,000
Q1 2022 May 04, 2022	SELL	$4.26 - $7.48 $2,892 - $5,078	-679 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $3,225 - $5,092	679 New	679 $5,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.